Selecta Biosciences (NASDAQ:SELB) Posts Earnings Results, B

Selecta Biosciences (NASDAQ:SELB – Get Rating) announced its earnings results on Thursday. The company reported $0.03 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.09, MarketWatch Earnings reports. During the same period in the prior year, the firm earned ($0.14) earnings per share. SELB stock traded down $0.10 during mid-day […]

Related Keywords

Thomson Reuter , Timothya Springer , Selecta Biosciences , Securities Exchange Commission , Squarepoint Ops , Virtu Financial , Zacks Investment Research , Selecta Biosciences Company Profile Get Rating , Selecta Biosciences Inc , Invesco Ltd , Get Rating , Marketwatch Earnings , Investment Research , Director Timothy , Exchange Commission , Biosciences Company Profile , Synthetic Vaccine Particles , Nasdaq Selb , Selb , Medical , Earnings ,